Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Burden of Candidemia in the United States, 2017.

Tsay SV, Mu Y, Williams S, Epson E, Nadle J, Bamberg WM, Barter DM, Johnston HL, Farley MM, Harb S, Thomas S, Bonner LA, Harrison LH, Hollick R, Marceaux K, Mody RK, Pattee B, Shrum Davis S, Phipps EC, Tesini BL, Gellert AB, Zhang AY, Schaffner W, Hillis S, Ndi D, Graber CR, Jackson BR, Chiller T, Magill S, Vallabhaneni S.

Clin Infect Dis. 2020 Feb 28. pii: ciaa193. doi: 10.1093/cid/ciaa193. [Epub ahead of print]

PMID:
32107534
2.

Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017.

McGee L, Chochua S, Li Z, Mathis S, Rivers J, Metcalf B, Ryan A, Alden N, Farley MM, Harrison LH, Snippes Vagnone P, Lynfield R, Smelser C, Muse A, Thomas AR, Schrag S, Beall BW.

Clin Infect Dis. 2020 Feb 15. pii: ciaa151. doi: 10.1093/cid/ciaa151. [Epub ahead of print]

PMID:
32060499
3.

Invasive Nontypeable Haemophilus influenzae Infection Among Adults With HIV in Metropolitan Atlanta, Georgia, 2008-2018.

Collins LF, Havers FP, Tunali A, Thomas S, Clennon JA, Wiley Z, Tobin-D'Angelo M, Parrott T, Read TD, Satola SW, Petit RA 3rd, Farley MM.

JAMA. 2019 Dec 24;322(24):2399-2410. doi: 10.1001/jama.2019.18800.

PMID:
31860046
4.

Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.

Novosad SA, Mu Y, Winston LG, Johnston H, Basiliere E, Olson DM, Farley MM, Revis A, Wilson L, Perlmutter R, Holzbauer SM, Whitten T, Phipps EC, Dumyati GK, Beldavs ZG, Ocampo VLS, Davis CM, Kainer M, Gerding DN, Guh AY.

J Gen Intern Med. 2020 Feb;35(2):412-419. doi: 10.1007/s11606-019-05386-9. Epub 2019 Nov 25.

PMID:
31768906
5.

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17.

Zhang AY, Shrum S, Williams S, Petnic S, Nadle J, Johnston H, Barter D, VonBank B, Bonner L, Hollick R, Marceaux K, Harrison L, Schaffner W, Tesini BL, Farley MM, Pierce RA, Phipps E, Mody RK, Chiller TM, Jackson BR, Vallabhaneni S.

Clin Infect Dis. 2019 Nov 2. pii: ciz1061. doi: 10.1093/cid/ciz1061. [Epub ahead of print]

PMID:
31676903
6.

Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.

Toda M, Williams SR, Berkow EL, Farley MM, Harrison LH, Bonner L, Marceaux KM, Hollick R, Zhang AY, Schaffner W, Lockhart SR, Jackson BR, Vallabhaneni S.

MMWR Surveill Summ. 2019 Sep 27;68(8):1-15. doi: 10.15585/mmwr.ss6808a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2019 Oct 18;68(41):934.

7.

Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015.

Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Hill M, Schaffner W, Lindegren ML, Thomas A, Billing L, Bennett N, Spina N, Bargsten M, Lynfield R, Eckel S, Ryan P, Yousey-Hindes K, Herlihy R, Kirley PD, Garg S, Anderson EJ.

Clin Infect Dis. 2019 Jul 11. pii: ciz638. doi: 10.1093/cid/ciz638. [Epub ahead of print]

PMID:
31298691
8.

Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection.

Band VI, Hufnagel DA, Jaggavarapu S, Sherman EX, Wozniak JE, Satola SW, Farley MM, Jacob JT, Burd EM, Weiss DS.

Nat Microbiol. 2019 Oct;4(10):1627-1635. doi: 10.1038/s41564-019-0480-z. Epub 2019 Jun 17.

PMID:
31209306
9.

Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis-Active Bacterial Core Surveillance Sites, 2011-2016.

McNamara LA, Potts CC, Blain A, Topaz N, Apostol M, Alden NB, Petit S, Farley MM, Harrison LH, Triden L, Muse A, Poissant T, Wang X, MacNeil JR.

Open Forum Infect Dis. 2019 Apr 15;6(5):ofz190. doi: 10.1093/ofid/ofz190. eCollection 2019 May.

10.

Risk factors for community-associated Clostridioides difficile infection in young children.

Weng MK, Adkins SH, Bamberg W, Farley MM, Espinosa CC, Wilson L, Perlmutter R, Holzbauer S, Whitten T, Phipps EC, Hancock EB, Dumyati G, Nelson DS, Beldavs ZG, Ocampo V, Davis CM, Rue B, Korhonen L, McDonald LC, Guh AY.

Epidemiol Infect. 2019 Jan;147:e172. doi: 10.1017/S0950268819000372.

11.

A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance.

Wozniak JE, Band VI, Conley AB, Rishishwar L, Burd EM, Satola SW, Hardy DJ, Tsay R, Farley MM, Jacob JT, Dumyati G, Jordan IK, Weiss DS.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00107-19. doi: 10.1128/AAC.00107-19. Print 2019 May.

12.

Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016.

Francois Watkins LK, McGee L, Schrag SJ, Beall B, Jain JH, Pondo T, Farley MM, Harrison LH, Zansky SM, Baumbach J, Lynfield R, Snippes Vagnone P, Miller LA, Schaffner W, Thomas AR, Watt JP, Petit S, Langley GE.

JAMA Intern Med. 2019 Apr 1;179(4):479-488. doi: 10.1001/jamainternmed.2018.7269.

13.

Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.

Milucky J, Carvalho MG, Rouphael N, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Lessa FC; Adult Pneumococcal Carriage Study Group.

Vaccine. 2019 Feb 14;37(8):1094-1100. doi: 10.1016/j.vaccine.2018.12.075. Epub 2019 Jan 23.

14.

Streptococcus infantis, Streptococcus mitis, and Streptococcus oralis Strains With Highly Similar cps5 Loci and Antigenic Relatedness to Serotype 5 Pneumococci.

Pimenta F, Gertz RE Jr, Park SH, Kim E, Moura I, Milucky J, Rouphael N, Farley MM, Harrison LH, Bennett NM, Bigogo G, Feikin DR, Breiman R, Lessa FC, Whitney CG, Rajam G, Schiffer J, da Gloria Carvalho M, Beall B.

Front Microbiol. 2019 Jan 8;9:3199. doi: 10.3389/fmicb.2018.03199. eCollection 2018.

15.

Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance.

Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner W, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ.

JAMA Pediatr. 2019 Mar 1;173(3):224-233. doi: 10.1001/jamapediatrics.2018.4826. Erratum in: JAMA Pediatr. 2019 Mar 1;173(3):296. JAMA Pediatr. 2019 May 1;173(5):502.

16.

Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.

Guh AY, Hatfield KM, Winston LG, Martin B, Johnston H, Brousseau G, Farley MM, Wilson L, Perlmutter R, Phipps EC, Dumyati GK, Nelson D, Hatwar T, Kainer MA, Paulick AL, Karlsson M, Gerding DN, McDonald LC.

Clin Infect Dis. 2019 Oct 30;69(10):1667-1674. doi: 10.1093/cid/ciz009.

PMID:
30615074
17.

Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule.

Lessa FC, Milucky J, Rouphael NG, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Gertz RE, Rajam G, Carvalho MDG, Beall B, Whitney CG.

Sci Rep. 2018 Dec 19;8(1):17959. doi: 10.1038/s41598-018-35921-3.

18.

Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011-2015.

Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Kirley PD, Herlihy R, Yousey-Hindes K, Monroe ML, Ladisky M, Lynfield R, Baumbach J, Spina N, Bennett N, Billing L, Thomas A, Schaffner W, Price A, Garg S, Anderson EJ.

J Pediatric Infect Dis Soc. 2019 Dec 27;8(6):539-549. doi: 10.1093/jpids/piy101.

PMID:
30358877
19.

Emergence of Localized Serogroup W Meningococcal Disease in the United States - Georgia, 2006-2016.

Moore AE, MacNeil JR, Wang X, Joseph SJ, Lorentzson L, Thomas S, Tunali A, Parrott T, Farley MM, Tobin-D'Angelo M.

MMWR Morb Mortal Wkly Rep. 2018 Aug 17;67(32):894-897. doi: 10.15585/mmwr.mm6732a5.

20.

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.

Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, Olson DM, Wilson L, Perlmutter R, Winston LG, Parker E, Bamberg W, Beldavs ZG, Ocampo V, Karlsson M, Gerding DN, McDonald LC.

Open Forum Infect Dis. 2017 Oct 26;4(4):ofx171. doi: 10.1093/ofid/ofx171. eCollection 2017 Fall.

21.

Invasive Methicillin-Resistant Staphylococcus aureus USA500 Strains from the U.S. Emerging Infections Program Constitute Three Geographically Distinct Lineages.

Frisch MB, Castillo-Ramírez S, Petit RA 3rd, Farley MM, Ray SM, Albrecht VS, Limbago BM, Hernandez J, See I, Satola SW, Read TD.

mSphere. 2018 May 2;3(3). pii: e00571-17. doi: 10.1128/mSphere.00571-17. eCollection 2018 May-Jun.

22.

Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009-2015.

Benedict K, Roy M, Kabbani S, Anderson EJ, Farley MM, Harb S, Harrison LH, Bonner L, Wadu VL, Marceaux K, Hollick R, Beldavs ZG, Zhang AY, Schaffner W, Graber CR, Derado G, Chiller TM, Lockhart SR, Vallabhaneni S.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e78-e85. doi: 10.1093/jpids/piy009.

PMID:
29522195
23.

Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection.

Band VI, Satola SW, Burd EM, Farley MM, Jacob JT, Weiss DS.

mBio. 2018 Mar 6;9(2). pii: e02448-17. doi: 10.1128/mBio.02448-17.

24.

Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015.

Soeters HM, Blain A, Pondo T, Doman B, Farley MM, Harrison LH, Lynfield R, Miller L, Petit S, Reingold A, Schaffner W, Thomas A, Zansky SM, Wang X, Briere EC.

Clin Infect Dis. 2018 Aug 31;67(6):881-889. doi: 10.1093/cid/ciy187.

25.

Intrinsic Neuronal Stress Response Pathways in Injury and Disease.

Farley MM, Watkins TA.

Annu Rev Pathol. 2018 Jan 24;13:93-116. doi: 10.1146/annurev-pathol-012414-040354. Review.

PMID:
29414247
26.

Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

Guh AY, Mu Y, Baggs J, Winston LG, Bamberg W, Lyons C, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, Dumyati G.

Am J Infect Control. 2018 Jul;46(7):840-842. doi: 10.1016/j.ajic.2017.11.026. Epub 2018 Jan 9.

28.

Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA.

Link-Gelles R, Westreich D, Aiello AE, Shang N, Weber DJ, Rosen JB, Motala T, Mascola L, Eason J, Scherzinger K, Holtzman C, Reingold AL, Barnes M, Petit S, Farley MM, Harrison LH, Zansky S, Thomas A, Schaffner W, McGee L, Whitney CG, Moore MR.

BMJ Open. 2017 Aug 28;7(8):e017715. doi: 10.1136/bmjopen-2017-017715.

29.

Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult.

Larhammar M, Huntwork-Rodriguez S, Jiang Z, Solanoy H, Sengupta Ghosh A, Wang B, Kaminker JS, Huang K, Eastham-Anderson J, Siu M, Modrusan Z, Farley MM, Tessier-Lavigne M, Lewcock JW, Watkins TA.

Elife. 2017 Apr 25;6. pii: e20725. doi: 10.7554/eLife.20725.

30.

Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000-2008.

Harris CM, Wu HM, Li J, Hall HI, Lee A, Zell E, Harrison LH, Petit S, Farley MM, Lynfield R, Miller L, Nichols M, Reingold A, Schaffner W, Thomas A, MacNeil JR, Clark TA, Cohn AC.

Open Forum Infect Dis. 2016 Dec 20;3(4):ofw226. doi: 10.1093/ofid/ofw226. eCollection 2016 Oct.

31.

Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014.

Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, Hudson Jain J, Lynfield R.

Pediatrics. 2016 Dec;138(6). pii: e20162013.

32.

Remodeling of the postsynaptic plasma membrane during neural development.

Tulodziecka K, Diaz-Rohrer BB, Farley MM, Chan RB, Di Paolo G, Levental KR, Waxham MN, Levental I.

Mol Biol Cell. 2016 Nov 7;27(22):3480-3489. Epub 2016 Aug 17.

33.

Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.

Havers F, Sokolow L, Shay DK, Farley MM, Monroe M, Meek J, Daily Kirley P, Bennett NM, Morin C, Aragon D, Thomas A, Schaffner W, Zansky SM, Baumbach J, Ferdinands J, Fry AM.

Clin Infect Dis. 2016 Nov 15;63(10):1304-1311. Epub 2016 Aug 2.

PMID:
27486114
34.

Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009.

Blain AE, Mandal S, Wu H, MacNeil JR, Harrison LH, Farley MM, Lynfield R, Miller L, Nichols M, Petit S, Reingold A, Schaffner W, Thomas A, Zansky SM, Anderson R, Harcourt BH, Mayer LW, Clark TA, Cohn AC.

Open Forum Infect Dis. 2016 Jul 13;3(3):ofw152. eCollection 2016 Sep.

35.

Ultrastructural analysis of bacteriophage Φ29 during infection of Bacillus subtilis.

Farley MM, Tu J, Kearns DB, Molineux IJ, Liu J.

J Struct Biol. 2017 Feb;197(2):163-171. doi: 10.1016/j.jsb.2016.07.019. Epub 2016 Jul 29.

36.

Utility of Keywords from Chest Radiograph Reports for Pneumonia Surveillance Among Hospitalized Patients with Influenza: The CDC Influenza Hospitalization Surveillance Network, 2008-2009.

Bramley AM, Chaves SS, Dawood FS, Doshi S, Reingold A, Miller L, Yousey-Hindes K, Farley MM, Ryan P, Lynfield R, Baumbach J, Zansky S, Bennett N, Thomas A, Schaffner W, Finelli L, Jain S.

Public Health Rep. 2016 May-Jun;131(3):483-90.

37.

Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.

Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R, Aragon D, Zansky SM, Watt JP, Cieslak PR, Angeles K, Harrison LH, Petit S, Beall B, Van Beneden CA.

Clin Infect Dis. 2016 Aug 15;63(4):478-86. doi: 10.1093/cid/ciw248. Epub 2016 Apr 22.

38.

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.

Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Holtzman C, Harrison LH, Zansky SM, Rosen JB, Reingold A, Scherzinger K, Thomas A, Guevara RE, Motala T, Eason J, Barnes M, Petit S, Farley MM, McGee L, Jorgensen JH, Whitney CG.

Lancet Respir Med. 2016 May;4(5):399-406. doi: 10.1016/S2213-2600(16)00052-7. Epub 2016 Mar 14.

PMID:
26987984
39.

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.

Tomczyk S, Lynfield R, Schaffner W, Reingold A, Miller L, Petit S, Holtzman C, Zansky SM, Thomas A, Baumbach J, Harrison LH, Farley MM, Beall B, McGee L, Gierke R, Pondo T, Kim L.

Clin Infect Dis. 2016 May 1;62(9):1119-25. doi: 10.1093/cid/ciw067. Epub 2016 Feb 7.

PMID:
26908787
40.

Minicells, Back in Fashion.

Farley MM, Hu B, Margolin W, Liu J.

J Bacteriol. 2016 Mar 31;198(8):1186-95. doi: 10.1128/JB.00901-15. Print 2016 Apr. Review.

41.

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.

Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2016 Jan 18;3(1):ofv196. doi: 10.1093/ofid/ofv196. eCollection 2016 Jan.

42.

The Impact of Obesity and Diabetes on the Risk of Disease and Death due to Invasive Group A Streptococcus Infections in Adults.

Langley G, Hao Y, Pondo T, Miller L, Petit S, Thomas A, Lindegren ML, Farley MM, Dumyati G, Como-Sabetti K, Harrison LH, Baumbach J, Watt J, Van Beneden C.

Clin Infect Dis. 2016 Apr 1;62(7):845-52. doi: 10.1093/cid/civ1032. Epub 2015 Dec 23.

PMID:
26703865
43.

Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014.

Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, Beldavs ZG, Derado G, Pham CD, Lockhart SR, Smith RM.

Open Forum Infect Dis. 2015 Dec 14;2(4):ofv163. doi: 10.1093/ofid/ofv163. eCollection 2015 Dec.

44.

Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.

Vallabhaneni S, Almendares O, Farley MM, Reno J, Smith ZT, Stein B, Magill SS, Smith RM, Cleveland AA, Lessa FC.

Epidemiol Infect. 2016 May;144(7):1440-4. doi: 10.1017/S0950268815003027. Epub 2015 Nov 26.

PMID:
26608090
45.

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep.

46.

Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults.

Chaves SS, Pérez A, Miller L, Bennett NM, Bandyopadhyay A, Farley MM, Fowler B, Hancock EB, Kirley PD, Lynfield R, Ryan P, Morin C, Schaffner W, Sharangpani R, Lindegren ML, Tengelsen L, Thomas A, Hill MB, Bradley KK, Oni O, Meek J, Zansky S, Widdowson MA, Finelli L.

Clin Infect Dis. 2015 Dec 15;61(12):1807-14. doi: 10.1093/cid/civ733. Epub 2015 Sep 2.

PMID:
26334053
47.

Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Coinfection Among Adults With Candidemia in Atlanta, GA, 2008-2012.

Reno J, Doshi S, Tunali AK, Stein B, Farley MM, Ray SM, Jacob JT.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1298-304. doi: 10.1017/ice.2015.185. Epub 2015 Aug 27.

PMID:
26310725
48.

Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008.

Garg S, Jain S, Dawood FS, Jhung M, Pérez A, D'Mello T, Reingold A, Gershman K, Meek J, Arnold KE, Farley MM, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Zansky S, Bennett N, Thomas A, Schaffner W, Finelli L.

BMC Infect Dis. 2015 Aug 26;15:369. doi: 10.1186/s12879-015-1004-y.

49.

Twenty Years of Active Bacterial Core Surveillance.

Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C.

Emerg Infect Dis. 2015 Sep;21(9):1520-8. doi: 10.3201/eid2109.141333.

50.

Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates.

Millman AJ, Reed C, Kirley PD, Aragon D, Meek J, Farley MM, Ryan P, Collins J, Lynfield R, Baumbach J, Zansky S, Bennett NM, Fowler B, Thomas A, Lindegren ML, Atkinson A, Finelli L, Chaves SS.

Emerg Infect Dis. 2015 Sep;21(9):1595-601. doi: 10.3201/eid2109.141665.

Supplemental Content

Loading ...
Support Center